RNRMarketResearch.com

2020: Active Pharmaceutical Ingredient Market Analysis by (Oncology, diabetes, Orthopedic, CNS, Nephrology, Ophthalmology)

Press Release   •   May 27, 2016 05:50 EDT

The active pharmaceutical ingredient market by type is categorized into innovative API and generic API. The innovative APIs segment accounted for highest share of the total API market in 2015. Patent protection of innovative APIs and higher prices compared to their generic equivalent are major factors driving the market growth for this segment.

Complete report on Active Pharmaceutical Ingredient Market spread across 206 Pages, Profiling 13 Companies and Supported with 121 Tables and 56 Figures is now available at http://www.reportsnreports.com/reports/431843-active-pharmaceutical-ingredient-market-by-type-innovative-generic-type-of-synthesis-synthetic-biotech-type-of-manufacturer-captive-merchant-therapy-oncology-diabetes-orthopedic-cns-nephrology-ophthalmology-global-forecast-to-2020.html

The active pharmaceutical ingredient market, by type of manufacturer, is segmented into captive and merchant manufacturers. The captive manufacturers segment accounted for major share of the total API market. The API market is expected to be dominated by captive manufacturers in 2015; however, it is slowly losing its share to contract manufacturers, owing to the complexity and high expenses associated with in-house manufacturing of API as well as the increased competition from emerging contract manufacturers.

Active Pharmaceutical Ingredient Market, by Therapeutic Area

  • Oncology
  • Diabetes
  • Cardiovascular disorders
  • CAN and neurological disorders
  • Pain management
  • Orthopedic disorders
  • Nephrology
  • Ophthalmology
  • Pulmonology
  • Gastrointestinal disorders
  • Endocrinology

The merchant manufacturing segment is segmented into innovative merchant API and generic merchant API. The innovative merchant APIs market is estimated to account for the major share of larger share in 2015; however, the growth of this market is expected to slow down due to imminent patent cliff, increasing cost of innovative drugs, and significant growth opportunities for generic merchant APIs market in emerging markets of India, China, and Latin America that offer low-cost manufacturing.

Interested in this report, Report copy of this research is available now

http://www.reportsnreports.com/contacts/requestsample.aspx?name=431843

North America accounts for the highest share of the global APIs market. The overall technological advancements in this region coupled with factors like increase in lifestyle and age related disorders in this region, the increase in demand for specialty biological and specialty drugs and increasing government focus on generics following the implementation of the Patient Protection and Affordable Care Act is driving the growth of this market.

Major factors driving the market growth are increasing global incidence of lifestyle and age-related diseases as well as cancer, technological advances in API manufacturing, increased awareness among people for better personal healthcare, government initiatives to increase availability and accessibility for better healthcare, and development of biologics and high potency API. On the other hand, stringent regulatory guidelines and global economic recession are some of the factors that may hinder the growth this market.

Key market players Teva Pharmaceuticals limited (Israel), Sun Pharmaceuticals Industries Limited (India), Dr. Reddy’s Laboratories Ltd. (India), Aurobindo (India), Novartis International AG (Switzerland), Boehringer Ingelheim (Germany), Albemarle Corporation (U.S.), Sigma Aldrich (U.S.), Mylan (U.K.), Allergan plc. (Ireland).

Click now for more Details, Quiries and Discount and Other Information on this study “Active Pharmaceutical Ingredient Market by type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech), Type of Manufacturer (Captive, Merchant), Therapy (Oncology, diabetes, Orthopedic, CNS, Nephrology, Ophthalmology) - Global Forecast to 2020research report can be requested at http://www.reportsnreports.com/contacts/discount.aspx?name=431843

This market study covers the different components of the active pharmaceutical ingredient market. In this report the API market is segmented of the basis of type of API which include innovative and generic API, on the basis of type of synthesis which include Synthetic and Biotech API, on the basis of type of manufacturer which included captive and merchant manufacturers and on the basis of therapeutic categories. These segments are covered for arriving at global market size for 2014 to 2020.

About Us:

ReportsandReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel: +1-888-391-5441
sales@reportsandreports.com